Physician profile
David B Morehead
NPI 1295744035
$3,685.37
in general payments reported to CMS, 2019-2025
26 companies · $612 in 2025
The $612 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $17.42 · 2021: $302 · 2022: $324 · 2023: $1,449 · 2024: $880 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $1,441.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,527.61 | 2023-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Abbvie INC. | $319.11 | 2021-2025 | |
| Pfizer INC. | $294.02 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $254.48 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $215.65 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $157.64 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $142.10 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $94.76 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $83.74 | 2019-2025 | |
| Organon LLC | $80.34 | 2021-2023 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $74.92 | 2021-2023 | |
| Daiichi Sankyo INC. | $58.44 | 2019-2021 | |
| Therapeuticsmd, INC. | $57.53 | 2019-2022 | |
| Zest Holdings, LLC | $55.42 | 2024 | |
| Avion Pharmaceuticals | $53.97 | 2021-2023 | Balcoltra |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $41.05 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $28.81 | 2023 | Exparel |
| Meditrina | $20.28 | 2025 | |
| Aspira Women'S Health INC | $19.72 | 2023 | Ova1 |
| Vertex Pharmaceuticals Incorporated | $19.48 | 2025 | |
| Evofem Biosciences, INC. | $16.91 | 2021 | |
| Coopersurgical, INC. | $16.20 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.55 | 2019 | |
| Gynesonics, INC. | $14.02 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $13.47 | 2022 | |
| Allergan, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Morehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.